{"id":68914,"date":"2025-06-04T12:00:00","date_gmt":"2025-06-04T12:00:00","guid":{"rendered":"https:\/\/www.africa-press.net\/senegal\/politique\/immunotherapie-precoce-ameliore-survie-cancer-poumon"},"modified":"2025-06-05T02:17:10","modified_gmt":"2025-06-05T02:17:10","slug":"immunotherapie-precoce-ameliore-survie-cancer-poumon","status":"publish","type":"post","link":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon","title":{"rendered":"Immunoth\u00e9rapie Pr\u00e9coce Am\u00e9liore Survie Cancer Poumon"},"content":{"rendered":"<p><span style=\"color: #ff6600\"><strong>Africa-Press &#8211; Senegal. <\/strong><\/span>000 morts par an, c\u2019est toujours le sombre bilan du cancer du poumon en France. Malgre\u0301 des avance\u0301es re\u0301gulie\u0300res dans sa prise en charge, les chiffres des cancers dits \u00ab non a\u0300 petites cellules \u00bb, les plus fre\u0301quents, restent en effet mauvais, la plupart des cas e\u0301tant malheureusement souvent de\u0301tecte\u0301s a\u0300 un stade avance\u0301 et non ope\u0301rable. \u00ab Me\u0302me chez les patients ope\u0301re\u0301s, la survie est limite\u0301e \u00bb, insiste le Pr Nicolas Girard, pneumologue, chef du de\u0301partement d\u2019oncologie me\u0301dicale a\u0300 l\u2019Institut Curie. Car ces cancers sont en effet tre\u0300s agressifs, leur risque de rechute demeurant tre\u0300s e\u0301leve\u0301, 30% a\u0300 55 % des patients ope\u0301re\u0301s de\u0301veloppant une re\u0301cidive, des microme\u0301tastases non de\u0301celables e\u0301tant parfois pre\u0301sentes de\u0300s le moment du diagnostic.<\/p>\n<p><b>Gagner du temps sur la tumeur<\/b><\/p>\n<p>Toutefois, bonne nouvelle a\u0300 l\u2019ASCO 2025 avec l\u2019e\u0301tude internationale dite CheckMate-816 coordonne\u0301e en France par le Pr Girard. Simultane\u0301ment publie\u0301e dans le New England Journal of Medicine le me\u0302me jour que sa pre\u0301sentation a\u0300 l\u2019ASCO, elle de\u0301montre sans ambigui\u0308te\u0301 que l\u2019ajout d\u2019une immunothe\u0301rapie (nivolumab, Opdivo, laboratoires BMS) avant l\u2019intervention chirurgicale permet de re\u0301duire les rechutes et de gue\u0301rir environ 25% des patients. Ici, tout se passe deux mois avant la chirurgie, avec une prise associe\u0301e d\u2019immunothe\u0301rapie (3 injections intraveineuses) administre\u0301es en me\u0302me temps que les trois cycles de chimiothe\u0301rapie.<\/p>\n<p>Prescrire une immunothe\u0301rapie le plus pre\u0301cocement possible est en fait une strate\u0301gie de\u0301ja\u0300 discute\u0301e depuis 2021, l\u2019objectif e\u0301tant e\u0301videmment de gagner du temps sur la tumeur. D\u2019ailleurs, de\u0300s 2022, les premiers re\u0301sultats de CheckMate avaient re\u0301ve\u0301le\u0301 que la combinaison the\u0301rapeutique permettait une re\u0301duction de pre\u0300s de 40% du risque de re\u0301cidive. Mais jusqu\u2019a\u0300 pre\u0301sent, il n\u2019y avait pas encore de donne\u0301es formelles de\u0301montrant que cette re\u0301duction des rechutes conduisait a\u0300 une augmentation du nombre de patients gue\u0301ris. C\u2019est de\u0301sormais chose faite avec des re\u0301sultats finaux communique\u0301s cette anne\u0301e sur la survie globale, 65% des patients traite\u0301s par les deux mole\u0301cules e\u0301tant encore en vie 5 ans apre\u0300s, contre 55 % pour ceux ayant rec\u0327u la chimiothe\u0301rapie seule. \u00ab CheckMate est le premier essai de phase 3 de\u0301montrant cate\u0301goriquement que la chimio-immunothe\u0301rapie ne\u0301oadjuvante ame\u0301liore significativement la survie globale des patients \u00bb, souligne le Pr Girard.<\/p>\n<p><b>Une tumeur vide\u0301e des cellules cance\u0301reuses<\/b><\/p>\n<p>D\u2019autre part, \u00ab dans 25 % des cas, la tumeur retire\u0301e par les chirurgiens e\u0301tait totalement vide\u0301e de ses cellules tumorales et remplace\u0301e par des globules blancs \u00bb, pointe l\u2019oncologue. Un avantage conside\u0301rable, ces patients e\u0301tant conside\u0301re\u0301s comme gue\u0301ris ! D\u2019autres strate\u0301gies avec des immunothe\u0301rapies administre\u0301es avant mais aussi apre\u0300s l\u2019intervention sont a\u0300 l\u2019e\u0301tude mais a\u0300 ce jour et en France, la mole\u0301cule Optivo est la seule immunothe\u0301rapie disponible en France dans le cadre de cette utilisation pre\u0301coce dite en ne\u0301o adjuvant. \u00ab Ces progre\u0300s significatifs rappellent que plus un cancer est de\u0301tecte\u0301 to\u0302t, plus les options the\u0301rapeutiques sont efficaces et les chances de gue\u0301rison e\u0301leve\u0301es. D\u2019ou\u0300 l\u2019importance vitale du de\u0301pistage pre\u0301coce du cancer du poumon et la mise en place d\u2019initiatives pour e\u0301valuer le de\u0301pistage organise\u0301, comme nous le faisons a\u0300 l\u2019Institut Curie, a\u0300 travers notre e\u0301tude Opti-Depist-Mut \u00bb, insiste le Pr Girard.<\/p>\n<p>Vous avez plus de 50 ans, e\u0302tes un homme ou une femme, fumez ou e\u0302tes un ancien fumeur sevre\u0301 depuis moins de 10 ans et habitez en Ile-de-France? OPTI-DEPIST-MUT est faite pour vous. Ouverte depuis cette anne\u0301e, cette e\u0301tude pilote unique en Ile-de-France est mene\u0301e en partenariat avec l\u2019Institut Mutualiste Montsouris et le Centre de Sante\u0301 du Square de la Mutualite\u0301, il suffit de les contacter et de remplir ici le questionnaire.<\/p>\n<p><strong>Pour plus d&rsquo;informations et d&rsquo;analyses sur la <span style=\"color: #ff6600\">Senegal<\/span>, suivez <span style=\"color: #ff6600\">Africa-Press<\/span><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Africa-Press &#8211; Senegal. 000 morts par an, c\u2019est toujours le sombre bilan du cancer du poumon en France. Malgre\u0301 des avance\u0301es re\u0301gulie\u0300res dans sa prise en charge, les chiffres des cancers dits \u00ab non a\u0300 petites cellules \u00bb, les plus fre\u0301quents, restent en effet mauvais, la plupart des cas e\u0301tant malheureusement souvent de\u0301tecte\u0301s a\u0300 un [&hellip;]<\/p>\n","protected":false},"author":82,"featured_media":68913,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22,10],"tags":[44],"class_list":["post-68914","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-divers","category-toutes-les-actualites","tag-senegal-2"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.1 (Yoast SEO v27.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Immunoth\u00e9rapie Pr\u00e9coce Am\u00e9liore Survie Cancer Poumon - Senegal<\/title>\n<meta name=\"description\" content=\"000 morts par an, c\u2019est toujours le sombre bilan du cancer du poumon en France. Malgre\u0301 des avance\u0301es re\u0301gulie\u0300res dans ...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunoth\u00e9rapie Pr\u00e9coce Am\u00e9liore Survie Cancer Poumon\" \/>\n<meta property=\"og:description\" content=\"000 morts par an, c\u2019est toujours le sombre bilan du cancer du poumon en France. Malgre\u0301 des avance\u0301es re\u0301gulie\u0300res dans ...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon\" \/>\n<meta property=\"og:site_name\" content=\"Senegal\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-04T12:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-05T02:17:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/06\/sm_1749118404.479444.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"cfeditorfr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"cfeditorfr\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon\"},\"author\":{\"name\":\"cfeditorfr\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1\"},\"headline\":\"Immunoth\u00e9rapie Pr\u00e9coce Am\u00e9liore Survie Cancer Poumon\",\"datePublished\":\"2025-06-04T12:00:00+00:00\",\"dateModified\":\"2025-06-05T02:17:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon\"},\"wordCount\":713,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/06\/sm_1749118404.479444.jpg\",\"keywords\":[\"Senegal\"],\"articleSection\":[\"Divers\",\"Toutes les actualit\u00e9s\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon\",\"url\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon\",\"name\":\"Immunoth\u00e9rapie Pr\u00e9coce Am\u00e9liore Survie Cancer Poumon - Senegal\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/06\/sm_1749118404.479444.jpg\",\"datePublished\":\"2025-06-04T12:00:00+00:00\",\"dateModified\":\"2025-06-05T02:17:10+00:00\",\"author\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1\"},\"description\":\"000 morts par an, c\u2019est toujours le sombre bilan du cancer du poumon en France. Malgre\u0301 des avance\u0301es re\u0301gulie\u0300res dans ...\",\"breadcrumb\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon#primaryimage\",\"url\":\"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/06\/sm_1749118404.479444.jpg\",\"contentUrl\":\"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/06\/sm_1749118404.479444.jpg\",\"width\":1200,\"height\":900,\"caption\":\"Immunoth\u00e9rapie Pr\u00e9coce Am\u00e9liore Survie Cancer Poumon\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.africa-press.net\/senegal\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Immunoth\u00e9rapie Pr\u00e9coce Am\u00e9liore Survie Cancer Poumon\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#website\",\"url\":\"https:\/\/www.africa-press.net\/senegal\/\",\"name\":\"Africa Press | Senegal | Homepage\",\"description\":\"Just another Africa News Agency Sites site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.africa-press.net\/senegal\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1\",\"name\":\"cfeditorfr\",\"url\":\"https:\/\/www.africa-press.net\/senegal\/author\/cfeditorfr\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Immunoth\u00e9rapie Pr\u00e9coce Am\u00e9liore Survie Cancer Poumon - Senegal","description":"000 morts par an, c\u2019est toujours le sombre bilan du cancer du poumon en France. Malgre\u0301 des avance\u0301es re\u0301gulie\u0300res dans ...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon","og_locale":"fr_FR","og_type":"article","og_title":"Immunoth\u00e9rapie Pr\u00e9coce Am\u00e9liore Survie Cancer Poumon","og_description":"000 morts par an, c\u2019est toujours le sombre bilan du cancer du poumon en France. Malgre\u0301 des avance\u0301es re\u0301gulie\u0300res dans ...","og_url":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon","og_site_name":"Senegal","article_published_time":"2025-06-04T12:00:00+00:00","article_modified_time":"2025-06-05T02:17:10+00:00","og_image":[{"width":1200,"height":900,"url":"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/06\/sm_1749118404.479444.jpg","type":"image\/jpeg"}],"author":"cfeditorfr","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"cfeditorfr","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon#article","isPartOf":{"@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon"},"author":{"name":"cfeditorfr","@id":"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1"},"headline":"Immunoth\u00e9rapie Pr\u00e9coce Am\u00e9liore Survie Cancer Poumon","datePublished":"2025-06-04T12:00:00+00:00","dateModified":"2025-06-05T02:17:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon"},"wordCount":713,"commentCount":0,"image":{"@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/06\/sm_1749118404.479444.jpg","keywords":["Senegal"],"articleSection":["Divers","Toutes les actualit\u00e9s"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon","url":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon","name":"Immunoth\u00e9rapie Pr\u00e9coce Am\u00e9liore Survie Cancer Poumon - Senegal","isPartOf":{"@id":"https:\/\/www.africa-press.net\/senegal\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon#primaryimage"},"image":{"@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/06\/sm_1749118404.479444.jpg","datePublished":"2025-06-04T12:00:00+00:00","dateModified":"2025-06-05T02:17:10+00:00","author":{"@id":"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1"},"description":"000 morts par an, c\u2019est toujours le sombre bilan du cancer du poumon en France. Malgre\u0301 des avance\u0301es re\u0301gulie\u0300res dans ...","breadcrumb":{"@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon#primaryimage","url":"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/06\/sm_1749118404.479444.jpg","contentUrl":"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/06\/sm_1749118404.479444.jpg","width":1200,"height":900,"caption":"Immunoth\u00e9rapie Pr\u00e9coce Am\u00e9liore Survie Cancer Poumon"},{"@type":"BreadcrumbList","@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/immunotherapie-precoce-ameliore-survie-cancer-poumon#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.africa-press.net\/senegal\/"},{"@type":"ListItem","position":2,"name":"Immunoth\u00e9rapie Pr\u00e9coce Am\u00e9liore Survie Cancer Poumon"}]},{"@type":"WebSite","@id":"https:\/\/www.africa-press.net\/senegal\/#website","url":"https:\/\/www.africa-press.net\/senegal\/","name":"Africa Press | Senegal | Homepage","description":"Just another Africa News Agency Sites site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.africa-press.net\/senegal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1","name":"cfeditorfr","url":"https:\/\/www.africa-press.net\/senegal\/author\/cfeditorfr"}]}},"_links":{"self":[{"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/posts\/68914","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/users\/82"}],"replies":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/comments?post=68914"}],"version-history":[{"count":0,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/posts\/68914\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/media\/68913"}],"wp:attachment":[{"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/media?parent=68914"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/categories?post=68914"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/tags?post=68914"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}